Atropine Dosing for Cholinesterase Inhibitor Toxicity
ورودیهای بالینی بیمار
حداقل ۰.۱ — حداکثر ۳۰۰ • واحد: kg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
The Atropine Dosing for Cholinesterase Inhibitor Toxicity calculates assessing acute poisoning severity, antidote indications, and fatal toxicity trajectory. Key inputs include patient type. Scores guide administering specific antidote therapy, gastrointestinal decontamination, and continuous telemetry monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Doses atropine for cholinesterase inhibitor toxicity from prescription drugs, nerve gas, or insecticides
Clinical Indication
The Atropine Dosing for Cholinesterase Inhibitor Toxicity is indicated for bedside clinical practice to support Doses atropine for cholinesterase inhibitor toxicity from prescription drugs, nerve gas, or insecticides. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute pharmaceutical overdose, agricultural pesticide ingestion, toxic gas inhalation, or venomous envenomation. Clinical application is indicated across Poison control centers, acute toxicology wards, emergency resuscitation rooms, and intensive care.
Limitations & Contraindications
Initial serum concentrations for sustained-release or co-ingested anticholinergic agents may falsely appear low before delayed absorption peaks.
Clinical Pearls & Action Plan
Rapid clinical toxidrome identification guides immediate antidote administration; do not wait for confirmatory toxicology assays.
Initial dose: Pediatric = 0.02 mg/kg (up to adult max); Adult mild = 1-2 mg; Adult severe = 3-5 mg. Double dose every 5 minutes until atropinization achieved. Continuous infusion = 10% of total initial doses per hour.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| patient_type | string | Yes | Patient age category |
| weight | float | No | Patient weight (required for pediatric patients)(kg) |
| severity | string | Yes | Severity of cholinesterase inhibitor toxicity |
Evidence-Based References (EBM)
- Howland MA. Antidotes in Depth: Atropine. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR, eds. Goldfrank's Toxicologic Emergencies. 10th ed. New York, NY: McGraw-Hill; 2015.
- Abedin MJ, Sayeed AA, Basher A, Maude RJ, Hoque G, Faiz MA. Open-label randomized clinical trial of atropine bolus injection versus incremental boluses plus infusion for organophosphate poisoning in Bangladesh. Clin Toxicol (Phila). 2012 Jun;50(5):433-40.
- Eddleston M, Dawson A, Karalliedde L, Dissanayake W, Hittarage A, Azher S, et al. Early management after self-poisoning with an organophosphorus or carbamate pesticide - a treatment protocol for junior doctors. Crit Care. 2004 Dec;8(6):R391-7.